From September 26, 2023 to September 30, 2023, the company has repurchased 311,958 shares, representing 0.18% for CNY 35.02 million. With this, the company has completed the repurchase of 311,958 shares, representing 0.18% for CNY 35.02 million under the buyback announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.55 HKD | +1.47% | +9.34% | +3.10% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.10% | 1.98B | |
-2.43% | 187B | |
-1.78% | 106B | |
-4.22% | 66.9B | |
+0.91% | 49.45B | |
+16.50% | 48B | |
+4.06% | 40.84B | |
+3.34% | 26.48B | |
+1.30% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.